Senior insider sale
ORIC PHARMACEUTICALS, INC. — senior position signals high conviction
$76.8K
6.40K shares
What this filing means
HEYMAN RICHARD A. plans to sell 6.40K shares of ORIC PHARMACEUTICALS, INC. valued at approximately $76.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2026ACC: 0001968582-26-000038
Director
Since Apr 2020
6.40K
Shares to sell
$76.8K
Approx. market value
6.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/31/2015
6.40KTotal acquired6.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2015 | Stock Option Exercise Cash | 6.40K | — |
| Total | 6.40K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
6.40K
Market value
$76.8K
1/16/2026
Total
Units
6.40K
Value
$76.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/16/2026 | 6.40K | $76.8K | Nasdaq | Planned |
| Total | 6.40K | $76.8K | ||